NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC2
|
ENSG00000101096.15 | nuclear factor of activated T cells 2 |
NFATC3
|
ENSG00000072736.14 | nuclear factor of activated T cells 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFATC3 | hg19_v2_chr16_+_68119764_68119868 | -0.87 | 2.6e-02 | Click! |
NFATC2 | hg19_v2_chr20_-_50179368_50179392 | 0.31 | 5.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_138188351 | 1.93 |
ENST00000421450.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr7_-_41742697 | 1.83 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
chr16_-_85969774 | 1.20 |
ENST00000598933.1
|
RP11-542M13.3
|
RP11-542M13.3 |
chr14_-_21562671 | 1.17 |
ENST00000554923.1
|
ZNF219
|
zinc finger protein 219 |
chr1_+_209941942 | 1.04 |
ENST00000487271.1
ENST00000477431.1 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr14_-_51863853 | 1.02 |
ENST00000556762.1
|
RP11-255G12.3
|
RP11-255G12.3 |
chr15_+_45722727 | 0.99 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
chr7_+_22766766 | 0.93 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr6_+_138188378 | 0.90 |
ENST00000420009.1
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr20_+_44637526 | 0.90 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr2_+_162949939 | 0.83 |
ENST00000432251.1
|
AC008063.3
|
AC008063.3 |
chr8_+_55466915 | 0.81 |
ENST00000522711.2
|
RP11-53M11.3
|
RP11-53M11.3 |
chr3_-_161089289 | 0.80 |
ENST00000497137.1
|
SPTSSB
|
serine palmitoyltransferase, small subunit B |
chr4_-_122148620 | 0.80 |
ENST00000509841.1
|
TNIP3
|
TNFAIP3 interacting protein 3 |
chr5_+_140514782 | 0.77 |
ENST00000231134.5
|
PCDHB5
|
protocadherin beta 5 |
chr3_-_100565249 | 0.77 |
ENST00000495591.1
ENST00000383691.4 ENST00000466947.1 |
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
chr3_-_141747950 | 0.74 |
ENST00000497579.1
|
TFDP2
|
transcription factor Dp-2 (E2F dimerization partner 2) |
chr21_+_35553045 | 0.73 |
ENST00000416145.1
ENST00000430922.1 ENST00000419881.2 |
LINC00310
|
long intergenic non-protein coding RNA 310 |
chr6_-_112081113 | 0.72 |
ENST00000517419.1
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr1_+_67632083 | 0.72 |
ENST00000347310.5
ENST00000371002.1 |
IL23R
|
interleukin 23 receptor |
chr12_+_113354341 | 0.68 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr6_+_31105426 | 0.67 |
ENST00000547221.1
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1 |
chr4_-_71532207 | 0.67 |
ENST00000543780.1
ENST00000391614.3 |
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr14_+_103589789 | 0.63 |
ENST00000558056.1
ENST00000560869.1 |
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr8_+_55467072 | 0.62 |
ENST00000602362.1
|
RP11-53M11.3
|
RP11-53M11.3 |
chr11_-_9482010 | 0.62 |
ENST00000596206.1
|
AC132192.1
|
LOC644656 protein; Uncharacterized protein |
chr2_-_228244013 | 0.62 |
ENST00000304568.3
|
TM4SF20
|
transmembrane 4 L six family member 20 |
chr5_+_159895275 | 0.62 |
ENST00000517927.1
|
MIR146A
|
microRNA 146a |
chr13_-_30160925 | 0.59 |
ENST00000450494.1
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr17_-_39093672 | 0.59 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
chr17_+_27047570 | 0.56 |
ENST00000472628.1
ENST00000578181.1 |
RPL23A
|
ribosomal protein L23a |
chr14_+_91709103 | 0.55 |
ENST00000553725.1
|
CTD-2547L24.3
|
HCG1816139; Uncharacterized protein |
chr6_-_133055815 | 0.55 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
chr6_+_31916733 | 0.54 |
ENST00000483004.1
|
CFB
|
complement factor B |
chr11_-_126174186 | 0.52 |
ENST00000524964.1
|
RP11-712L6.5
|
Uncharacterized protein |
chr8_-_23712312 | 0.52 |
ENST00000290271.2
|
STC1
|
stanniocalcin 1 |
chr6_-_133055896 | 0.51 |
ENST00000367927.5
ENST00000425515.2 ENST00000207771.3 ENST00000392393.3 ENST00000450865.2 ENST00000392394.2 |
VNN3
|
vanin 3 |
chr11_-_69867159 | 0.51 |
ENST00000528507.1
|
RP11-626H12.2
|
RP11-626H12.2 |
chr11_-_119293872 | 0.49 |
ENST00000524970.1
|
THY1
|
Thy-1 cell surface antigen |
chr12_-_57037284 | 0.47 |
ENST00000551570.1
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
chr3_-_114035026 | 0.47 |
ENST00000570269.1
|
RP11-553L6.5
|
RP11-553L6.5 |
chr4_+_39408470 | 0.46 |
ENST00000257408.4
|
KLB
|
klotho beta |
chr7_+_28452130 | 0.46 |
ENST00000357727.2
|
CREB5
|
cAMP responsive element binding protein 5 |
chr7_+_66800928 | 0.45 |
ENST00000430244.1
|
RP11-166O4.5
|
RP11-166O4.5 |
chr17_+_4853442 | 0.45 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
chr1_-_173020056 | 0.44 |
ENST00000239468.2
ENST00000404377.3 |
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18 |
chrX_-_133792480 | 0.44 |
ENST00000359237.4
|
PLAC1
|
placenta-specific 1 |
chr1_+_81106951 | 0.43 |
ENST00000443565.1
|
RP5-887A10.1
|
RP5-887A10.1 |
chr6_+_106546808 | 0.42 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr14_-_92413727 | 0.42 |
ENST00000267620.10
|
FBLN5
|
fibulin 5 |
chr14_-_77889860 | 0.41 |
ENST00000555603.1
|
NOXRED1
|
NADP-dependent oxidoreductase domain containing 1 |
chr3_+_99357319 | 0.41 |
ENST00000452013.1
ENST00000261037.3 ENST00000273342.4 |
COL8A1
|
collagen, type VIII, alpha 1 |
chr2_+_66918558 | 0.40 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3
|
AC007392.3 |
chr14_+_75988851 | 0.40 |
ENST00000555504.1
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr16_-_3306587 | 0.40 |
ENST00000541159.1
ENST00000536379.1 ENST00000219596.1 ENST00000339854.4 |
MEFV
|
Mediterranean fever |
chr14_-_76447336 | 0.39 |
ENST00000556285.1
|
TGFB3
|
transforming growth factor, beta 3 |
chr17_+_27046988 | 0.39 |
ENST00000496182.1
|
RPL23A
|
ribosomal protein L23a |
chr17_-_61045902 | 0.39 |
ENST00000581596.1
|
RP11-180P8.3
|
RP11-180P8.3 |
chr6_+_106534192 | 0.38 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr18_-_25739260 | 0.38 |
ENST00000413878.1
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal) |
chr17_-_15522826 | 0.38 |
ENST00000395906.3
|
CDRT1
|
CMT1A duplicated region transcript 1 |
chr17_+_18647326 | 0.38 |
ENST00000395667.1
ENST00000395665.4 ENST00000308799.4 ENST00000301938.4 |
FBXW10
|
F-box and WD repeat domain containing 10 |
chr17_-_7120498 | 0.38 |
ENST00000485100.1
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chr17_+_27047244 | 0.37 |
ENST00000394938.4
ENST00000394935.3 ENST00000355731.4 |
RPL23A
|
ribosomal protein L23a |
chr12_-_49582978 | 0.37 |
ENST00000301071.7
|
TUBA1A
|
tubulin, alpha 1a |
chrX_+_152683780 | 0.37 |
ENST00000338647.5
|
ZFP92
|
ZFP92 zinc finger protein |
chr1_-_204135450 | 0.36 |
ENST00000272190.8
ENST00000367195.2 |
REN
|
renin |
chr17_+_45331184 | 0.35 |
ENST00000559488.1
ENST00000571680.1 ENST00000435993.2 |
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
chr12_-_7244469 | 0.35 |
ENST00000538050.1
ENST00000536053.2 |
C1R
|
complement component 1, r subcomponent |
chr8_-_57123815 | 0.35 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
chr15_-_40401062 | 0.34 |
ENST00000354670.4
ENST00000559701.1 ENST00000557870.1 ENST00000558774.1 |
BMF
|
Bcl2 modifying factor |
chr10_+_30723105 | 0.34 |
ENST00000375322.2
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr10_+_30723045 | 0.33 |
ENST00000542547.1
ENST00000415139.1 |
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr18_-_3247084 | 0.32 |
ENST00000609924.1
|
RP13-270P17.3
|
RP13-270P17.3 |
chr5_+_140207536 | 0.32 |
ENST00000529310.1
ENST00000527624.1 |
PCDHA6
|
protocadherin alpha 6 |
chr22_+_38203898 | 0.32 |
ENST00000323205.6
ENST00000248924.6 ENST00000445195.1 |
GCAT
|
glycine C-acetyltransferase |
chr13_-_81801115 | 0.31 |
ENST00000567258.1
|
LINC00564
|
long intergenic non-protein coding RNA 564 |
chr11_+_18417948 | 0.31 |
ENST00000542179.1
|
LDHA
|
lactate dehydrogenase A |
chr17_+_16120512 | 0.30 |
ENST00000581006.1
ENST00000584797.1 ENST00000498772.2 ENST00000225609.5 ENST00000395844.4 ENST00000477745.1 |
PIGL
|
phosphatidylinositol glycan anchor biosynthesis, class L |
chrX_+_133941218 | 0.30 |
ENST00000370784.4
ENST00000370785.3 |
FAM122C
|
family with sequence similarity 122C |
chr12_+_49961990 | 0.30 |
ENST00000551063.1
|
PRPF40B
|
PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae) |
chr14_+_24837226 | 0.30 |
ENST00000554050.1
ENST00000554903.1 ENST00000554779.1 ENST00000250373.4 ENST00000553708.1 |
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
chr12_+_54393880 | 0.29 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
chrY_-_15591485 | 0.29 |
ENST00000382896.4
ENST00000537580.1 ENST00000540140.1 ENST00000545955.1 ENST00000538878.1 |
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
chr11_+_102188272 | 0.29 |
ENST00000532808.1
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr14_-_92413353 | 0.28 |
ENST00000556154.1
|
FBLN5
|
fibulin 5 |
chr8_+_128748466 | 0.28 |
ENST00000524013.1
ENST00000520751.1 |
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog |
chr2_+_172543919 | 0.28 |
ENST00000452242.1
ENST00000340296.4 |
DYNC1I2
|
dynein, cytoplasmic 1, intermediate chain 2 |
chr7_-_139756791 | 0.28 |
ENST00000489809.1
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr5_+_66124590 | 0.28 |
ENST00000490016.2
ENST00000403666.1 ENST00000450827.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr3_-_71353892 | 0.28 |
ENST00000484350.1
|
FOXP1
|
forkhead box P1 |
chr2_+_162272605 | 0.28 |
ENST00000389554.3
|
TBR1
|
T-box, brain, 1 |
chr17_-_7120525 | 0.27 |
ENST00000447163.1
ENST00000399506.2 ENST00000302955.6 |
DLG4
|
discs, large homolog 4 (Drosophila) |
chr7_-_150754935 | 0.27 |
ENST00000297518.4
|
CDK5
|
cyclin-dependent kinase 5 |
chr12_-_49582593 | 0.26 |
ENST00000295766.5
|
TUBA1A
|
tubulin, alpha 1a |
chr14_+_65170820 | 0.26 |
ENST00000555982.1
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chr9_-_73483926 | 0.26 |
ENST00000396283.1
ENST00000361823.5 |
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3 |
chrX_+_84498989 | 0.26 |
ENST00000395402.1
|
ZNF711
|
zinc finger protein 711 |
chr22_-_30642728 | 0.26 |
ENST00000403987.3
|
LIF
|
leukemia inhibitory factor |
chrX_+_9431324 | 0.26 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr17_+_67759813 | 0.26 |
ENST00000587241.1
|
AC003051.1
|
AC003051.1 |
chrX_-_100662881 | 0.26 |
ENST00000218516.3
|
GLA
|
galactosidase, alpha |
chr14_-_88200641 | 0.26 |
ENST00000556168.1
|
RP11-1152H15.1
|
RP11-1152H15.1 |
chr14_-_24615805 | 0.26 |
ENST00000560410.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr5_-_115910630 | 0.25 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr5_-_150466692 | 0.25 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
chr12_-_96793142 | 0.25 |
ENST00000552262.1
ENST00000551816.1 ENST00000552496.1 |
CDK17
|
cyclin-dependent kinase 17 |
chr5_-_111093759 | 0.25 |
ENST00000509979.1
ENST00000513100.1 ENST00000508161.1 ENST00000455559.2 |
NREP
|
neuronal regeneration related protein |
chr4_+_22999152 | 0.25 |
ENST00000511453.1
|
RP11-412P11.1
|
RP11-412P11.1 |
chrX_-_139866723 | 0.25 |
ENST00000370532.2
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa |
chr6_+_12290586 | 0.25 |
ENST00000379375.5
|
EDN1
|
endothelin 1 |
chr11_+_101983176 | 0.25 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr17_-_61776522 | 0.25 |
ENST00000582055.1
|
LIMD2
|
LIM domain containing 2 |
chr15_+_93443419 | 0.25 |
ENST00000557381.1
ENST00000420239.2 |
CHD2
|
chromodomain helicase DNA binding protein 2 |
chr12_-_92536433 | 0.25 |
ENST00000551563.2
ENST00000546975.1 ENST00000549802.1 |
C12orf79
|
chromosome 12 open reading frame 79 |
chr6_+_32407619 | 0.24 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr12_-_49582837 | 0.24 |
ENST00000547939.1
ENST00000546918.1 ENST00000552924.1 |
TUBA1A
|
tubulin, alpha 1a |
chr11_+_102188224 | 0.24 |
ENST00000263464.3
|
BIRC3
|
baculoviral IAP repeat containing 3 |
chr5_-_147162263 | 0.24 |
ENST00000333010.6
ENST00000265272.5 |
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr11_-_102714534 | 0.24 |
ENST00000299855.5
|
MMP3
|
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
chr14_-_89878369 | 0.24 |
ENST00000553840.1
ENST00000556916.1 |
FOXN3
|
forkhead box N3 |
chr11_-_85397167 | 0.24 |
ENST00000316398.3
|
CCDC89
|
coiled-coil domain containing 89 |
chr5_+_167718604 | 0.24 |
ENST00000265293.4
|
WWC1
|
WW and C2 domain containing 1 |
chr18_-_33047039 | 0.23 |
ENST00000591141.1
ENST00000586741.1 |
RP11-322E11.5
|
RP11-322E11.5 |
chr9_-_136283156 | 0.23 |
ENST00000371942.3
|
REXO4
|
REX4, RNA exonuclease 4 homolog (S. cerevisiae) |
chr1_+_149239529 | 0.23 |
ENST00000457216.2
|
RP11-403I13.4
|
RP11-403I13.4 |
chr5_+_140220769 | 0.23 |
ENST00000531613.1
ENST00000378123.3 |
PCDHA8
|
protocadherin alpha 8 |
chr2_-_113594279 | 0.23 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr11_+_18417813 | 0.23 |
ENST00000540430.1
ENST00000379412.5 |
LDHA
|
lactate dehydrogenase A |
chr22_-_19466643 | 0.23 |
ENST00000474226.1
|
UFD1L
|
ubiquitin fusion degradation 1 like (yeast) |
chr22_-_39640756 | 0.23 |
ENST00000331163.6
|
PDGFB
|
platelet-derived growth factor beta polypeptide |
chr2_-_165424973 | 0.23 |
ENST00000543549.1
|
GRB14
|
growth factor receptor-bound protein 14 |
chr11_-_46142948 | 0.23 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
chr7_+_20686946 | 0.22 |
ENST00000443026.2
ENST00000406935.1 |
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
chr11_-_2924970 | 0.22 |
ENST00000533594.1
|
SLC22A18AS
|
solute carrier family 22 (organic cation transporter), member 18 antisense |
chr1_-_246670519 | 0.22 |
ENST00000388985.4
ENST00000490107.1 |
SMYD3
|
SET and MYND domain containing 3 |
chr12_-_89918982 | 0.22 |
ENST00000549504.1
|
POC1B
|
POC1 centriolar protein B |
chr1_+_186265399 | 0.22 |
ENST00000367486.3
ENST00000367484.3 ENST00000533951.1 ENST00000367482.4 ENST00000367483.4 ENST00000367485.4 ENST00000445192.2 |
PRG4
|
proteoglycan 4 |
chr6_-_134495992 | 0.22 |
ENST00000475719.2
ENST00000367857.5 ENST00000237305.7 |
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr14_+_65171099 | 0.22 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
chrX_-_43832711 | 0.22 |
ENST00000378062.5
|
NDP
|
Norrie disease (pseudoglioma) |
chr6_-_26235206 | 0.22 |
ENST00000244534.5
|
HIST1H1D
|
histone cluster 1, H1d |
chr3_-_39195037 | 0.22 |
ENST00000273153.5
|
CSRNP1
|
cysteine-serine-rich nuclear protein 1 |
chr22_-_50699701 | 0.22 |
ENST00000395780.1
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr5_-_146461027 | 0.21 |
ENST00000394410.2
ENST00000508267.1 ENST00000504198.1 |
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta |
chr6_+_116832789 | 0.21 |
ENST00000368599.3
|
FAM26E
|
family with sequence similarity 26, member E |
chr7_-_121944491 | 0.21 |
ENST00000331178.4
ENST00000427185.2 ENST00000442488.2 |
FEZF1
|
FEZ family zinc finger 1 |
chr5_-_64777733 | 0.21 |
ENST00000381055.3
|
ADAMTS6
|
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
chr11_-_111749767 | 0.21 |
ENST00000542429.1
|
FDXACB1
|
ferredoxin-fold anticodon binding domain containing 1 |
chr22_-_19466683 | 0.21 |
ENST00000399523.1
ENST00000421968.2 ENST00000447868.1 |
UFD1L
|
ubiquitin fusion degradation 1 like (yeast) |
chr13_-_33780133 | 0.21 |
ENST00000399365.3
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr3_-_71632894 | 0.21 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr17_-_46657473 | 0.21 |
ENST00000332503.5
|
HOXB4
|
homeobox B4 |
chr11_+_34663913 | 0.21 |
ENST00000532302.1
|
EHF
|
ets homologous factor |
chr1_+_79115503 | 0.21 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr17_+_38334501 | 0.20 |
ENST00000541245.1
|
RAPGEFL1
|
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr18_-_3845293 | 0.20 |
ENST00000400145.2
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr12_+_6554021 | 0.20 |
ENST00000266557.3
|
CD27
|
CD27 molecule |
chr3_-_134092561 | 0.20 |
ENST00000510560.1
ENST00000504234.1 ENST00000515172.1 |
AMOTL2
|
angiomotin like 2 |
chr17_+_7387677 | 0.20 |
ENST00000322644.6
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr8_-_73793975 | 0.20 |
ENST00000523881.1
|
RP11-1145L24.1
|
RP11-1145L24.1 |
chr2_-_191885686 | 0.20 |
ENST00000432058.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr1_+_38022513 | 0.20 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr14_+_78227105 | 0.20 |
ENST00000439131.2
ENST00000355883.3 ENST00000557011.1 ENST00000556047.1 |
C14orf178
|
chromosome 14 open reading frame 178 |
chr10_-_50323543 | 0.20 |
ENST00000332853.4
ENST00000298454.3 |
VSTM4
|
V-set and transmembrane domain containing 4 |
chr15_-_65503801 | 0.20 |
ENST00000261883.4
|
CILP
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
chr2_+_149974684 | 0.20 |
ENST00000450639.1
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
chr11_+_34654011 | 0.20 |
ENST00000531794.1
|
EHF
|
ets homologous factor |
chr19_+_1041187 | 0.20 |
ENST00000531467.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr8_-_74495065 | 0.19 |
ENST00000523533.1
|
STAU2
|
staufen double-stranded RNA binding protein 2 |
chr16_+_66400533 | 0.19 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr12_-_2944184 | 0.19 |
ENST00000337508.4
|
NRIP2
|
nuclear receptor interacting protein 2 |
chr18_+_3451584 | 0.19 |
ENST00000551541.1
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr6_+_106535455 | 0.19 |
ENST00000424894.1
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr5_-_108063949 | 0.19 |
ENST00000606054.1
|
LINC01023
|
long intergenic non-protein coding RNA 1023 |
chr2_-_127963343 | 0.19 |
ENST00000335247.7
|
CYP27C1
|
cytochrome P450, family 27, subfamily C, polypeptide 1 |
chr10_-_75118611 | 0.19 |
ENST00000355577.3
ENST00000394865.1 ENST00000310715.3 ENST00000401621.2 |
TTC18
|
tetratricopeptide repeat domain 18 |
chr19_+_45690646 | 0.19 |
ENST00000591569.1
|
AC006126.3
|
Uncharacterized protein |
chr8_-_74884341 | 0.19 |
ENST00000284811.8
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) |
chr11_-_57089774 | 0.19 |
ENST00000527207.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr5_+_38845960 | 0.19 |
ENST00000502536.1
|
OSMR
|
oncostatin M receptor |
chr10_+_118305435 | 0.19 |
ENST00000369221.2
|
PNLIP
|
pancreatic lipase |
chr1_+_150254936 | 0.19 |
ENST00000447007.1
ENST00000369095.1 ENST00000369094.1 |
C1orf51
|
chromosome 1 open reading frame 51 |
chr11_-_119293903 | 0.19 |
ENST00000580275.1
|
THY1
|
Thy-1 cell surface antigen |
chr16_+_30211181 | 0.18 |
ENST00000395138.2
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
chr6_+_152011628 | 0.18 |
ENST00000404742.1
ENST00000440973.1 |
ESR1
|
estrogen receptor 1 |
chr5_+_38846101 | 0.18 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr20_+_33464238 | 0.18 |
ENST00000360596.2
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
chr6_+_26183958 | 0.18 |
ENST00000356530.3
|
HIST1H2BE
|
histone cluster 1, H2be |
chr17_+_79953310 | 0.18 |
ENST00000582355.2
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
chr7_-_111424462 | 0.18 |
ENST00000437129.1
|
DOCK4
|
dedicator of cytokinesis 4 |
chr12_+_46777450 | 0.18 |
ENST00000551503.1
|
RP11-96H19.1
|
RP11-96H19.1 |
chr10_+_90521163 | 0.18 |
ENST00000404459.1
|
LIPN
|
lipase, family member N |
chrX_+_135730297 | 0.18 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chrX_+_135730373 | 0.18 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr2_-_163100045 | 0.18 |
ENST00000188790.4
|
FAP
|
fibroblast activation protein, alpha |
chr17_-_56492989 | 0.18 |
ENST00000583753.1
|
RNF43
|
ring finger protein 43 |
chr12_-_7245018 | 0.18 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr11_+_64004888 | 0.17 |
ENST00000541681.1
|
VEGFB
|
vascular endothelial growth factor B |
chr18_-_3845321 | 0.17 |
ENST00000539435.1
ENST00000400147.2 |
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of osteoclast proliferation(GO:0090291) negative regulation of CD40 signaling pathway(GO:2000349) |
0.6 | 1.8 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 1.0 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 0.9 | GO:0002384 | hepatic immune response(GO:0002384) response to prolactin(GO:1990637) |
0.2 | 0.7 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.7 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.1 | 0.4 | GO:0042704 | detection of oxygen(GO:0003032) uterine wall breakdown(GO:0042704) |
0.1 | 0.8 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.1 | 0.5 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.6 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.1 | 0.1 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.1 | 0.3 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.1 | 0.6 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.3 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 0.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.2 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.1 | 0.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 1.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.6 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.2 | GO:1900241 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.1 | 0.2 | GO:1902336 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.1 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.1 | 0.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.3 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.0 | 0.2 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.0 | 0.2 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.0 | 0.4 | GO:2000809 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.0 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.1 | GO:1903660 | cellular response to mercury ion(GO:0071288) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.5 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.0 | 0.0 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
0.0 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.5 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.2 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) |
0.0 | 0.2 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.0 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0045416 | very-low-density lipoprotein particle remodeling(GO:0034372) positive regulation of interleukin-8 biosynthetic process(GO:0045416) regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.1 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.0 | 0.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 1.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.0 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.0 | 0.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.2 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.2 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0010157 | response to chlorate(GO:0010157) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) RNA repair(GO:0042245) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.0 | 0.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.1 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.0 | 0.1 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.0 | 0.3 | GO:0051001 | glycoside catabolic process(GO:0016139) glycosylceramide catabolic process(GO:0046477) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.1 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.0 | 0.6 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.0 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.0 | 0.2 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.1 | GO:0015692 | lead ion transport(GO:0015692) |
0.0 | 0.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.0 | 0.1 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 0.1 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.0 | 0.1 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.1 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.0 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 1.0 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.0 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.0 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.0 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.0 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:0046822 | regulation of nucleocytoplasmic transport(GO:0046822) |
0.0 | 0.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.6 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.2 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.7 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 0.6 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 1.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.2 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.2 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.0 | 0.4 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.1 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.0 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.0 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.8 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.2 | 0.6 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.2 | 2.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.7 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 1.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.5 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.0 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.0 | 0.1 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.0 | 0.1 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.0 | 0.2 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.0 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0005503 | all-trans retinal binding(GO:0005503) |
0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.0 | 0.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.1 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.1 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.0 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.0 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.1 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 1.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 0.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.0 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.0 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.1 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) aspartic-type endopeptidase inhibitor activity(GO:0019828) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.0 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.0 | 0.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.0 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 2.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 2.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 3.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 1.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 1.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |